CME Group (NASDAQ:CME) Earns Sell Rating from Rosenblatt Securities
Rosenblatt Securities reaffirmed their sell rating on shares of CME Group (NASDAQ:CME – Free Report) in a research report released on Thursday, Benzinga reports. The firm currently has a $180.00 target price on the financial services provider’s stock. A number of other research firms have also recently issued reports on CME. Bank of America upped […]